In keeping with this hypothesis, authors showed that high concentrations of TGF-β1 were found in patients suffering from both fatty liver and NASH, suggesting that these forms share more common aspects regarding their progression than previously thought [87]. This evidence concerns the gene TGFB1 and Hepatic steatosis.